Mononine Purple Book BLA 103957

BLA number
103957
Proprietary names
Mononine
Proper names
Coagulation Factor IX (Human)
Applicant
CSL Behring LLC
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001MononineCoagulation Factor IX (Human)351(a)1000IUFor InjectionIntravenousSingle-Dose VialDiscVoluntarily Revoked2000-03-17
002MononineCoagulation Factor IX (Human)351(a)500IUFor InjectionIntravenousSingle-Dose VialDiscVoluntarily Revoked2000-03-17

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2023-07-01U001Mononine351(a)DiscCSL Behring LLC
2023-07-01U002Mononine351(a)DiscCSL Behring LLC
2022-03-01U001Mononine351(a)RxCSL Behring LLC
2022-03-01U002Mononine351(a)RxCSL Behring LLC
2021-09-01U001Mononine351(a)RxCSL Behring LLC
2021-09-01U002Mononine351(a)RxCSL Behring LLC
2021-05-01U001Mononine351(a)RxCSL Behring LLC
2021-05-01U002Mononine351(a)RxCSL Behring LLC
2020-08-01R001Mononine351(a)RxCSL Behring LLC
2020-08-01R002Mononine351(a)RxCSL Behring LLC

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2023-07-01001Mononine351(a)DiscVoluntarily Revoked2000-03-17
2023-07-01002Mononine351(a)DiscVoluntarily Revoked2000-03-17
2022-03-01001Mononine351(a)RxVoluntarily Revoked2000-03-17
2022-03-01002Mononine351(a)RxVoluntarily Revoked2000-03-17
2020-08-01001Mononine351(a)RxLicensed2000-03-17
2020-08-01002Mononine351(a)RxLicensed2000-03-17